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Introduction
Clinical practice and research in the field of spondyloarthritis
(SpA) have changed dramatically in recent years due to the
advent of magnetic resonance imaging (MRI) and the
introduction of symptomatically highly effective yet expen-
sive anti-tumor necrosis factor alpha (TNFα) agents. While
physical and laboratory examinations are of limited diagnos-
tic value, MRI is regarded as the most sensitive imaging
modality for the detection of early inflammatory lesions in
the axial skeleton before any inflammatory changes can be
seen on standard radiography. However, plain radiography
continues to play a major role in evaluating potential disease-
modifying agents in the treatment of SpA.
Challenges in clinically suspected early
spondyloarthritis
Diagnosing SpA at an early disease stage remains a
challenge in routine practice, because physical examination
has limited sensitivity, while laboratory investigation has
limited specificity for this disorder. A combination of
historical features has been proposed as diagnostic criteria
[1], although elicitation of these historical items requires
standardization and validation is necessary in primary care
cohorts.
The modified New York classification criteria published
in 1984 [2] are still widely used in clinical practice for
making a diagnosis of ankylosing spondylitis (AS). These
classification criteria rely primarily on plain radiographic
features of sacroiliitis, which include erosions and sclerosis
that have high disease specificity, as required for classifi-
cation criteria. However, plain radiography is not helpful in
most patients with clinically suspected early AS because
only about 50% of patients with inflammatory back pain
have developed definite radiographic features of sacroiliitis
by 10 years of follow-up [3]. Hence, these criteria are not
ideal for making an early diagnosis in an individual patient.
Furthermore, defining reliable morphologic criteria that
distinguish equivocal (stage 1) from definite (stage 2)
sacroiliitis is notably difficult and is primarily quantitative.
Radiographic stage 2 sacroiliitis had only modest sensitivity
and specificity for AS, whether films were read by
rheumatologists or radiologists, and training did not
improve this [4]. Standard radiography serves primarily to
confirm late-stage disease and is not suitable for early
diagnosis.
In 2004, a literature review reported specificity, sensi-
tivity, and likelihood ratios for various clinical features,
laboratory findings and skeletal imaging techniques used in
clinical practice for diagnosing pre-radiographic AS [5].
When clinical features of inflammatory back pain and
positive HLA B27 status are present the probability of AS
is estimated at 59%. The presence of inflammatory lesions
on MRI is estimated to increase the probability of AS to
80–95%. The MRI studies on which these estimates were
based recruited small numbers of patients with inflamma-
tory and mechanical causes of back pain and so must be
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regarded as preliminary. MR evaluation consisted largely of
dynamic imaging of the sacroiliac (SI) joints with gadolin-
ium augmentation, which is costly and therefore unlikely to
be feasible in routine practice. Moreover, these estimates
depend greatly on the clinical criteria used to select patients
for further examination by MRI. In a cohort of 68 patients
with inflammatory back pain of less than 2 years’ duration,
assessment of structural changes by standard radiographs,
together with evaluation of inflammatory lesions on STIR
sequences, was optimal for the detection of sacroiliitis [6].
However, the frequency of abnormalities detected by MRI
was higher in patients meeting three sets (58%) as opposed
to only one set (7%) of clinical classification criteria for
SpA [7]. MRI is therefore most appropriately used in pre-
radiographic disease where there is a reasonable pre-test
probability based on clinical evaluation together with a
positive test for HLA B27.
The second most frequent region (after the SI joints)
affected by inflammation in SpA is the thoracic spine [8].
With conventional MRI the spine is imaged in the sagittal
orientation in two halves, a cervicothoracic and a thora-
columbar portion. It is important to scan and evaluate the
lateral portions of the thoracic spine, which include the
costovertebral and costotransverse joints since one study
has shown that inflammation is more common in the lateral
than in the central sagittal slices [9].
The histopathological basis of bone marrow signal
abnormalities seen on STIR and gadolinium-augmented
sequences in SpA remains to be determined. One study
demonstrated a direct correlation between the severity of
histopathological abnormalities observed on CT-guided
biopsies of the SI joints and the degree of gadolinium
augmentation observed with dynamic MRI [10]. A recent
study in 8 patients with long-standing disease undergoing
spinal extension surgery showed moderate correlation
between bone marrow inflammatory lesions on STIR
sequences and histopathological findings of interstitial
mononuclear cell infiltrates in zygapophyseal joints [11].
An MRI–histological correlation study of normal SI joints
found that the synovial part of this joint is confined to the
distal cartilaginous portion at the iliac side [12]. This
finding may explain why early inflammatory signs on MRI
of patients with clinically suspected SpA are often seen in
the inferior iliac portion of the SI joints [13].
Whole body MRI is a recently introduced modification
of conventional MRI that allows simultaneous assessment
of the entire spine, the SI joints, the shoulder, the pelvic
girdle, and the anterior chest wall in SpA [14]. Acquisition
of T1-weighted spin-echo and STIR images in the coronal
and sagittal planes takes 30 min to perform, which is
comparable to conventional imaging. Spatial resolution is
similar to that of standard MR examination. With its more
comprehensive assessment of inflammation in the entire
axial skeleton, whole body MRI is a promising tool for the
diagnostic work-up of patients with suspected early SpA,
and it may serve as an objective and quantitative measure
of inflammation.
In suspected pre-radiographic SpA, computed tomography
(CT) of the SI joints is no longer recommended for routine
diagnostic evaluation due to the increased exposure to
radiation, which is relevant to the younger SpA population.
In particular, the earliest features of SpA include synovitis and
capsulitis in the posterocaudal portion of the SI joints with
adjacent bone marrow edema and these features are not
captured on CT.
Limited studies that have compared imaging modalities
have shown that bone scintigraphy of the SI joints is less
sensitive than MRI in the diagnostic evaluation of inflam-
matory back pain [15, 16]. Its limited specificity is
highlighted by the observation of increased isotope uptake
in the SI joints after hopping on one leg [17]. Recent
systematic literature research concluded that scintigraphy of
the SI joints is of limited diagnostic value for clinically
suspected early SpA [18].
The importance of MRI as the imaging method of choice
for early detection of inflammation of the axial skeleton is
reinforced by its inclusion in the Assessment in Ankylosing
Spondylitis (ASAS) International Working Group recom-
mendations for the management of AS [19]. However, there
are still many issues that have to be clarified. We need
standardized morphologic definitions for acute and chronic
inflammatory lesions seen on MRI and an evaluation of
their specificity and sensitivity, particularly in comparison
to patients with mechanical back disorders. One of the most
relevant questions for clinical practice is whether the
apparently inflammatory lesions seen on MRI are indeed
predictive of future structural changes visible as radio-
graphic sacroiliitis and syndesmophyte formation. These
clinically highly relevant issues have to be addressed before
the radiographic sacroiliitis included in the modified New
York classification criteria may be supplanted by MRI in
formulating diagnostic criteria for early SpA.
Imaging in the assessment of a patient with established
spondyloarthritis unresponsive to standard treatment
Clinical and laboratory evaluation are limited in their ability
to discriminate between inflammatory and mechanical
sources of back pain. Consequently, MRI provides addi-
tional information regarding disease activity in a patient
with established AS who has failed conventional treatment.
This may be particularly useful before initiating therapy
with anti-TNFα agents and it may even be considered
desirable to obtain a baseline MRI before committing a
patient to long-term therapy with these agents.
488 Skeletal Radiol (2008) 37:487–490
Transdiscal fractures in an ankylosed spine (transverse
fractures through intervertebral syndesmophytes, the former
disk and the posterior elements of the spinal column) and
transvertebral fractures may occur after minor trauma, and
represent a serious complication with the risk of spinal cord
injury. If the diagnosis is initially missed, these transverse
spinal fractures may result in a painful intervertebral
pseudarthrosis, which may be mistaken for spinal inflam-
matory disease activity. These fractures may be difficult to
locate by standard radiography. The imaging methods of
choice are CT with high resolution multiplanar reconstruc-
tion and MRI; the combination of both imaging modalities
yields the highest sensitivity for detection of transverse
spinal fractures [20, 21].
Osteoporosis is a common complication, not only in
advanced SpA with spinal ankylosis, but may also occur
early in the disease course. Loss of bone mineral density
(BMD) correlates with the degree of inflammatory disease
activity and improves following treatment with anti-TNFα
agents [22]. Insufficiency fractures of vertebral endplates
after minor trauma may be a reason for prolonged back pain.
Low BMD at the femoral neck is associated with increased
vertebral fracture risk in AS patients [23]. Dual energy X-ray
absorptiometry screening should be considered not only in
patients with spinal fusion, but also in relatively short
duration disease (<10 years) if it has been marked by
persistently high inflammatory activity.
Imaging in the evaluation of response to therapeutic
intervention
Magnetic resonance imaging is rapidly gaining importance
as an objective measure of inflammation in the spine and SI
joints in AS and in complementing clinical and laboratory
evaluation of disease activity, particularly because the
primary validated measures of efficacy are patient self-
reports. Scoring indices based on MRI have been developed
that allow quantification of inflammation and are increas-
ingly used to assess treatment response in clinical trials
with the TNFα inhibitors etanercept, infliximab, and
adalimumab [24–26]. An international multireader exercise
evaluated three different MRI scoring methods for spinal
inflammation in AS [27]. All three methods are based on
the assessment of STIR sequences of the spine imaged in
the sagittal plane. Two of the methods (Berlin score; AS
spinal MRI activity [ASspiMRIa] score) score inflammato-
ry lesions in a single sagittal slice, while the third method
(Spondyloarthritis Research Consortium of Canada
[SPARCC]) scores lesions in consecutive sagittal slices
permitting three-dimensional assessment of the extent of
the lesion. Feasibility and discriminatory capacity were
comparable for all three scoring systems, but greater
reliability was observed with the SPARCC method. The
SPARCC group has also developed a scoring index for
quantification of inflammation in the SI joints. A recently
published randomized controlled trial of adalimumab in
active AS used MRI to assess disease activity both in the
spine and in the SI joints with the SPARCC methodology.
The SPARCC indices were shown to be reliable and highly
discriminatory between treatment groups, reinforcing their
value in the clinical trial assessment of new treatment
approaches [26].
At present, the suspicion of early axial SpA is mainly
based on clinical grounds. There is increasing evidence that
the recent advances in MRI will become essential in routine
care for patients with suspected SpA to enable an earlier
diagnosis of this potentially disabling disorder. In routine
clinical practice STIR and T1-weighted spin-echo se-
quences are sufficient. Contrast-enhanced images are costly
and have not been shown to offer any advantages. Imaging
of the spine should be included in diagnostic protocols for
SpA to ensure the evaluation of the costovertebral joints.
MRI is also valuable in clinical care of patients with
established SpA unresponsive to standard treatment, be-
cause it may not be possible to distinguish differing
pathologies on clinical grounds alone. Monitoring the
response to treatment in SpA by MRI is a focus of interest
in clinical research because most efficacy measures are
based on patient self-reports.
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